Source: Eur Respir J, 52 (3) 1801240; 10.1183/13993003.01240-2018
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Yüksel Peker, Patrick J. Strollo. New steps forward for obstructive sleep apnoea in the era of precision medicine. Eur Respir J, 52 (3) 1801240; 10.1183/13993003.01240-2018

Member's Comments

No comment yet.

Related content which might interest you: New technologies for diagnosis of obstructive sleep apnoea: the way to go? Source: Virtual Congress 2021 – Digital health meets sleep breathing disorders Year: 2021 Challenges and perspectives in obstructive sleep apnoea Source: Eur Respir J, 52 (3) 1702616; 10.1183/13993003.02616-2017 Year: 2018 From the laboratory to the bedside: the pharmacotherapy of obstructive sleep apnoea Source: Sleep and Breathing Conference 2021 Year: 2021 Development of a digital medicine solution for home-based obstructive sleep apnea phenotyping Source: Virtual Congress 2021 – From pathophysiology to different diagnostic modalities in sleep disordered breathing Year: 2021 Personalised medicine in sleep respiratory disorders: focus on obstructive sleep apnoea diagnosis and treatment Source: Eur Respir Rev, 26 (146) 170069; 10.1183/16000617.0069-2017 Year: 2017 Telemedicine(TM)-based strategy for management of obstructive sleep apnea (OSA): Virtual sleep unit Source: International Congress 2018 – New diagnostic tools for sleep and breathing and healthcare provision options Year: 2018 Advances in the surgical treatment of obstructive sleep apnoea Source: International Congress 2017 – Multidisciplinary management of sleep apnoea Year: 2017 Polissonographic findings of obstructive sleep apnea in children: are they the same for different age-groups? Source: Annual Congress 2007 - Sleep apnoea in childhood Year: 2007 Ato-oxy as the first successful pharmacotherapy for obstructive sleep apnoea Source: International Congress 2019 – New horizons for pharmacotherapy of sleep-disordered breathing: from bench to bedside Year: 2019 Personalised approach to treatment of children with obstructive sleep apnoea: what is the evidence? Source: Sleep and Breathing Conference 2021 Year: 2021 Treatment of obstructive and central sleep apnoea in heart failure: practical options Source: Eur Respir Rev 2007; 16: 183-188 Year: 2007 Surgical approaches to the treatment of obstructive sleep apnea Source: Virtual Congress 2020 – New technologies for the management of COPD and obstructive sleep apnea and the diagnosis of lung cancer Year: 2020 Diagnosis of obstructive sleep apnoea in children: standards for sleep study duration Source: International Congress 2019 – New developments in sleep-disordered breathing, gas exchange and lung function in children Year: 2019 Repeatability of the Delta 12s index to screen for paediatric obstructive sleep apnoea Source: Virtual Congress 2021 – Sleep across the lifespan in the new era of COVID - 19 Year: 2021 Diagnostic efficacy of the KaLinix® intelligent medical device for diagnosis of obstructive sleep apnea and hypopnea syndrome. Source: Virtual Congress 2020 – Screening methods and diagnostic tools for obstructive sleep apnoea Year: 2020 Screening for obstructive sleep apnoea in professional drivers Source: Breathe, 16 (1) 29364; 10.1183/20734735.0364-2019 Year: 2020 Treatment of obstructive and central sleep apnoea in heart failure: current concepts and perspectives Source: Annual Congress 2005 - PG12 - Sleep-related problems: treatment of obstructive sleep apnoea - current concepts and perspectives Year: 2005 Cardiovascular disorders in children with obstructive sleep apnea Source: Annual Congress 2005 - Sleep apnoea in children Year: 2005 Targeted hypoglossal neurostimulation for obstructive sleep apnoea: a 1-year pilot study Source: Eur Respir J 2013; 41: 360-367 Year: 2013 Positional therapy for obstructive sleep apnea: do your patients use it at home? Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea Year: 2009